Teva Pharmaceutical Industries Ltd. (TEVA)
44.50
+0.85
(+1.95%)
USD |
NYSE |
Nov 13, 16:00
44.36
-0.14
(-0.31%)
Pre-Market: 05:36
Teva Pharmaceutical Industries Price to Book Value : 6.509 for Nov. 13, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 13, 2026 | 6.509 |
| November 12, 2026 | 6.384 |
| November 11, 2026 | 6.324 |
| November 10, 2026 | 6.201 |
| November 09, 2026 | 6.285 |
| November 06, 2026 | 6.232 |
| November 05, 2026 | 6.111 |
| November 04, 2026 | 6.121 |
| November 03, 2026 | 6.130 |
| November 02, 2026 | 5.953 |
| October 30, 2026 | 6.156 |
| October 29, 2026 | 6.065 |
| October 28, 2026 | 5.846 |
| October 27, 2026 | 5.907 |
| October 26, 2026 | 5.843 |
| October 23, 2026 | 5.764 |
| October 22, 2026 | 5.881 |
| October 21, 2026 | 5.941 |
| October 20, 2026 | 5.975 |
| October 19, 2026 | 6.042 |
| October 16, 2026 | 6.070 |
| October 15, 2026 | 6.013 |
| October 14, 2026 | 5.956 |
| October 13, 2026 | 6.033 |
| October 12, 2026 | 6.022 |
| Date | Value |
|---|---|
| October 09, 2026 | 6.011 |
| October 08, 2026 | 5.741 |
| October 07, 2026 | 5.730 |
| October 06, 2026 | 5.723 |
| October 05, 2026 | 5.801 |
| October 02, 2026 | 5.782 |
| October 01, 2026 | 5.750 |
| September 30, 2026 | 5.792 |
| September 29, 2026 | 5.982 |
| September 28, 2026 | 5.842 |
| September 25, 2026 | 5.889 |
| September 24, 2026 | 6.044 |
| September 23, 2026 | 5.862 |
| September 22, 2026 | 5.938 |
| September 21, 2026 | 6.020 |
| September 18, 2026 | 5.857 |
| September 17, 2026 | 5.889 |
| September 16, 2026 | 5.790 |
| September 15, 2026 | 5.898 |
| September 14, 2026 | 5.818 |
| September 11, 2026 | 5.560 |
| September 10, 2026 | 5.462 |
| September 09, 2026 | 5.537 |
| September 08, 2026 | 5.524 |
| September 04, 2026 | 5.464 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Merck & Co., Inc. | 8.119 |
| Bristol Myers Squibb Co. | 5.540 |
| Eli Lilly & Co. | 33.74 |
| Pfizer Inc. | 1.850 |
| Sanofi | 1.629 |
Price to Book Value Related Metrics
| PE Ratio | 106.89 |
| PS Ratio | 3.024 |
| Price to Free Cash Flow | 42.64 |
| Price | 44.50 |
| Earnings Yield | 0.94% |
| Market Cap | 51.93B |
| Operating PE Ratio | 15.79 |
| Normalized PE Ratio | 28.29 |